| NCT ID | NCT07011082 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Healthy |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2024-11-18 |
| Primary Completion | 2029-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2024-11-18 with a primary completion date of 2029-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Young children aged 0-4 years may be exposed to adverse childhood experiences (ACEs) and/or early life adversity (ELA), which are linked with worse physical and mental health across their lifespan. On the other hand, positive childhood experiences (PCEs) can build resilience and prevent or protect against these detrimental outcomes. Data analyses will assess the interactions of ACEs, PCEs, parenting, and poverty on the early social psychology of childhood and develop objective measures for altered stress regulation using hair cortisol as a chronic stress biomarker.
Eligibility Criteria
Inclusion Criteria: 1. Normal, healthy children aged 6 months to 24 months and their mothers (or father, if mother is not able to participate). 2. Living in Santa Clara County, San Mateo County, or Alameda County in Northern California. 3. Willing to give their home address (in order to receive the study kits at home). 4. Committed to regular follow-up at 6-month intervals for the full study duration of 2 years. Exclusion Criteria: 1. Children with tinea capitis, alopecia areata, scalp eczema, dermatitis, or other scalp conditions. 2. Children exposed to systemic steroid therapy for any diagnosis in the 3 months prior to study entry. 3. Children receiving any other prescription drugs that alter HPA axis function or cortisol release, if the period of exposure is 2 weeks or longer within the 3 months prior to study entry. 4. Children with chronic medical conditions such as cystic fibrosis, sickle cell disease, asthma, eczema, or other chronic conditions. 5. Children with known developmental delay, Trisomy-21 and other chromosomal anomalies, seizure disorders, chronic pain, cerebral palsy, or other disabilities. 6. Children whose hair has received chemical exposures (e.g., dying, bleaching, chemical straightening, perming) in the 90 days prior to study entry or for 90 days before each follow-up appointment during the 2-year study period.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07011082 clinical trial?
This trial is open to participants of all sexes, aged 6 Months or older, up to 24 Months, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07011082 currently recruiting?
Yes, NCT07011082 is actively recruiting participants. Contact the research team at anandam@stanford.edu for enrollment information.
Where is the NCT07011082 trial being conducted?
This trial is being conducted at Palo Alto, United States.
Who is sponsoring the NCT07011082 clinical trial?
NCT07011082 is sponsored by Stanford University. The trial plans to enroll 600 participants.